Loading insider details...
Latest Form 4 (Sep 2, 2026): Grant/Award of 500,000 OTLK shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | Outlook Therapeutics, Inc. (OTLK) | Grant/Award | 500,000 | n/a |